OAM
CNMD icon

Oxford Asset Management’s CONMED CNMD Stock Holding History

Oxford Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16,897
Closed -$1.89M – 433
2019
Q4 		$1.89M Buy
+16,897
New +$1.8M 0.05% 453
2019
Q2 		– Sell
-26,073
Closed -$2.17M – 1735
2019
Q1 		$2.17M Buy
26,073
+6,571
+34% +$477K 0.05% 534
2018
Q4 		$1.25M Sell
19,502
-40,078
-67% -$2.74M 0.03% 742
2018
Q3 		$4.74M Buy
59,580
+25,113
+73% +$1.94M 0.1% 237
2018
Q2 		$2.52M Sell
34,467
-6,730
-16% -$458K 0.05% 525
2018
Q1 		$2.61M Buy
41,197
+24,044
+140% +$1.44M 0.06% 438
2017
Q4 		$878K Buy
17,153
+11,545
+206% +$601K 0.02% 986
2017
Q3 		$294K Buy
+5,608
New +$282K 0.01% 1345

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Oxford Asset Management's CNMD Position: Q1 2020 in Review

Oxford Asset Management sold out of CONMED (CNMD) in Q1 2020, closing a stake of 16,897 shares — an estimated $1.89M sold.

Oxford Asset Management first reported a position in CNMD in Q3 2017 and held it in 8 quarters. The position peaked at $4.74M in Q3 2018. 228 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

  • Oxford Asset Management reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 16,897 CONMED shares in Q1 2020, an estimated $1.89M.
  • Oxford Asset Management first reported a position in CONMED in Q3 2017 and held it in 8 quarters.
  • Oxford Asset Management's CONMED position peaked at $4.74M in Q3 2018.
  • 228 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.